anmelden
NYSE International 100
10.737,54
PKT
-12,72
PKT
-0,12
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu NYSE International 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 11.01.23 | ING Group Buy | Goldman Sachs Group Inc. | |
| 11.01.23 | Unilever Neutral | Goldman Sachs Group Inc. | |
| 11.01.23 | Nokia Outperform | Credit Suisse Group | |
| 11.01.23 | Deutsche Bank Buy | Warburg Research | |
| 10.01.23 | Mercedes-Benz Group (ex Daimler) Conviction Buy List | Goldman Sachs Group Inc. | |
| 10.01.23 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 10.01.23 | Philips Overweight | Barclays Capital | |
| 10.01.23 | Prudential Buy | Deutsche Bank AG | |
| 10.01.23 | Rio Tinto Hold | Deutsche Bank AG | |
| 10.01.23 | SAP Buy | Baader Bank | |
| 10.01.23 | Allianz Buy | Deutsche Bank AG | |
| 10.01.23 | SAP Buy | UBS AG | |
| 10.01.23 | ING Group Sector Perform | RBC Capital Markets | |
| 09.01.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 09.01.23 | Shell (ex Royal Dutch Shell) Buy | Deutsche Bank AG | |
| 09.01.23 | GSK Equal Weight | Barclays Capital | |
| 09.01.23 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
| 09.01.23 | AstraZeneca Overweight | Barclays Capital | |
| 09.01.23 | Shell (ex Royal Dutch Shell) Outperform | Credit Suisse Group | |
| 09.01.23 | Nutrien (Ex Potash Agrium) Underperform | Credit Suisse Group | |
| 09.01.23 | SAP Underperform | Jefferies & Company Inc. | |
| 09.01.23 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 09.01.23 | AstraZeneca Neutral | UBS AG | |
| 09.01.23 | Sanofi Neutral | UBS AG | |
| 09.01.23 | Novartis Neutral | UBS AG | |
| 09.01.23 | GSK Sell | UBS AG | |
| 09.01.23 | Vodafone Group Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 09.01.23 | Allianz Overweight | Morgan Stanley | |
| 09.01.23 | BP Conviction Buy List | Goldman Sachs Group Inc. | |
| 09.01.23 | Eni Buy | Goldman Sachs Group Inc. | |
| 09.01.23 | Shell (ex Royal Dutch Shell) Neutral | Goldman Sachs Group Inc. | |
| 09.01.23 | TotalEnergies Neutral | Goldman Sachs Group Inc. | |
| 09.01.23 | SAP Overweight | JP Morgan Chase & Co. | |
| 07.01.23 | UBS Neutral | Credit Suisse Group | |
| 06.01.23 | Deutsche Bank Underperform | Credit Suisse Group | |
| 06.01.23 | AstraZeneca Neutral | Credit Suisse Group | |
| 06.01.23 | Novartis Underperform | Credit Suisse Group | |
| 06.01.23 | Sanofi Outperform | Credit Suisse Group | |
| 06.01.23 | GSK Neutral | Credit Suisse Group | |
| 06.01.23 | Shell (ex Royal Dutch Shell) Buy | UBS AG |